| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615923 | Clinical Lymphoma Myeloma and Leukemia | 2017 | 7 Pages |
Abstract
The presence of sMPMTs was not a significant risk factor for patients with newly diagnosed hematological malignancies. It is important to provide adequate treatment for both hematological malignancies and solid tumors at the physician's discretion.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Satoshi Nishiwaki, Shingo Okuno, Kotaro Suzuki, Shingo Kurahashi, Isamu Sugiura,